BAC Reports - Research and Analysis

Publications found: 184,776
Sort by:

FibroGen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

FibroGen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ocular Therapeutix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ocular Therapeutix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Editas Medicine Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Editas Medicine Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PLx Pharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PLx Pharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Agios Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agios Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wave Life Sciences Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wave Life Sciences Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Karyopharm Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Karyopharm Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Phibro Animal Health Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Phibro Animal Health Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ionis Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ionis Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Xenon Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xenon Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AnaptysBio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AnaptysBio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ANI Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ANI Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ProQR Therapeutics NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ProQR Therapeutics NV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vaxart, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vaxart, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Eagle Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Eagle Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Mediwound Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mediwound Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ascendis Pharma AS Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ascendis Pharma AS Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pulmatrix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pulmatrix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Quotient Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quotient Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aratana Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aratana Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cellular Biomedicine Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellular Biomedicine Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cerecor Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cerecor Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Natera Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Natera Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Theravance Biopharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Theravance Biopharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Blueprint Medicines Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Blueprint Medicines Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

GlycoMimetics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

GlycoMimetics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Millendo Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Millendo Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioverativ Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioverativ Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Molecular Templates Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Molecular Templates Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cara Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cara Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Seres Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Seres Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kalvista Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kalvista Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Stemline Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stemline Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tetraphase Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tetraphase Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

VBI Vaccines Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VBI Vaccines Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Checkpoint Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Checkpoint Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Intellia Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Intellia Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aralez Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aralez Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

MacroGenics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MacroGenics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NewLink Genetics Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NewLink Genetics Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TherapeuticsMD Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TherapeuticsMD Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Five Prime Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Five Prime Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Endocyte Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Endocyte Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pacira BioSciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pacira BioSciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sarepta Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sarepta Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

K2M Group Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

K2M Group Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Merus BV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Merus BV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Myos Rens Technology Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Myos Rens Technology Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Portola Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Portola Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BOD Australia Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BOD Australia Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

98,003
4,916
4,667
4,028
3,602
2,685
2,535
2,522
2,389
2,274
2,251
2,078
1,850
1,647
1,614
1,443
1,372
1,231
1,145
1,035
879
860
859
681
679
648
648
555
442
427
390
362
361
359
296
295
270
265
241
240
234
225
221
215
187
182
181
181
181
181
181
181
181
181
181
181
181
180
179
173
149
148
134
134
120
105
103
97
94
93
92
90
83
79
79
75
73
73
73
72
63
63
62
59
54
49
48
46
39
36
36
34
29
29
29
25
24
22
15
13
6
5
2
1
1
1
563
561
529
481
416
263
261
237
207
183
182
180
177
164
121
120
120
119
119
79
78
77
73
73
65
65
64
64
63
63
61
61
61
61
61
61
61
61
60
60
60
60
60
60
60
60
60
59
59
59
59
59
59
59
59
59
59
59
59
59
59
59
59
59
59
28
24
20
12
9
9
8
7
6
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
74
17
16
15
14
6
5
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
62
18
1
2,540
1,014
545
464
433
371
344
335
316
267
262
241
185
146
146
138
138
127
121
121
98
81
79
77
75
71
68
67
64
63
63
62
61
61
61
61
61
61
61
60
50
38
35
30
27
26
22
21
16
13
8
8
7
6
4
4
4
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
633
60
4
1
85
12
184
123
193
68
256
194
74
74
27
4
2
1
1
1
3,996
1
2
451
110
84
74
71
62
3
53
1

Publishers

98,009
54,092
8,835
1,658
1,345
1,288
183
162
15,013
1,082
845
218
1,830
109
107

Regions

11,246
4,594
4,495
4,408
4,384
2,661
2,489
2,455
2,056
1,985
1,481
1,361
1,324
1,125
1,067
1,016
994
954
916
850
813
747
741
703
680
645
630
628
601
573
561
559
559
558
554
545
511
500
477
474
467
445
442
436
417
404
402
374
369
367
366
366
360
354
351
351
345
342
341
339
337
330
329
327
327
324
316
304
303
280
235
226
201
151
144
137
129
127
113
108
103
98
92
90
90
86
83
81
75
72
69
68
66
65
65
61
59
59
57
57
55
54
54
53
53
52
52
51
51
50
50
50
49
48
48
48
48
48
48
47
47
47
47
47
46
46
46
46
46
45
45
45
45
44
44
44
44
44
44
44
44
44
44
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
42
42
42
42
42
42
42
7
7
5
5
4
3
3
2
2
2
1
1
1
1
1
1
1
1
1

Price

—

Date

—

Pages

—

Offers